top of page


Centers for Medicare & Medicaid Services | CMS | 2024
CMS's Focuses on Sickle Cell Disease within the Cell and Gene Therapy Access Model The CMS declared that sickle cell disease (SCD) will...


CMS News | Medicare | Medicaid | 2023 | iPharmaCenter
November 21, 2023 Since the Opening of ACA Marketplace Coverage, 4.5 Million Selected Affordable Health Coverage Nearly 4.6 million...


Inflation Reduction Act | News | Updates | iPharmaCenter
October 03, 2023 All manufacturers of selected ten drugs agreed for price negotiation with CMS The Inflation Reduction Act, a...


CDC News Updates | Beyfortus recommended for RSV
September 23, 2023 CDC's ACIP endorsed Pfizer's RSV vaccine Pfizer is expanding its roster of recommended respiratory vaccines, endorsed...


FDA granted traditional approval for Leqmbi, CMS to provide broader coverage for the drug
The U.S. Food and Drug Administration (FDA) converted the approval of Leqembi (lecanemab) for treating Alzheimer's Disease from...
CMS Updates on mild Alzheimer’s disease
The Centers for Medicare & Medicaid Services provided new information on how individuals can obtain Medicare coverage for drugs that may...


CMS News | HHS | USA | Medicare, and Medicaid | Health insurance | Healthcare News
CMS announced that the Inflation Reduction Act would reduce the cost of prescription drugs and premiums of healthcare plans CMS announced...


CMS News
New payments terms announced for Medicare loans availed by providers The Centers for Medicare & Medicaid Services (CMS) announced amended...
bottom of page
